Human myeloid dendritic cells for cancer therapy: Does maturation matter? (original) (raw)

Transfected human dendritic cells to induce antitumor immunity

Hassan Rahimi

Gene Therapy, 1999

View PDFchevron_right

Loading of dendritic cells for immunotherapy

A. Van Nuffel

ISBT Science Series, 2013

View PDFchevron_right

Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation

Mayte Suarez-Farinas

Journal of Investigative Dermatology, 2009

View PDFchevron_right

Tumor's other immune targets: dendritic cells

Anna Lokshin, Watkins, Watkins, Galina Shurin

Journal of …, 1999

View PDFchevron_right

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

Gerty Schreibelt

Expert Review of Clinical Immunology, 2014

View PDFchevron_right

Targeted Cancer Therapy by Dendritic Cell Vaccine

Minako Abe

Cancer Treatment - Conventional and Innovative Approaches, 2013

View PDFchevron_right

Lack of Conventional Dendritic Cells Is Compatible with Normal Development and T Cell Homeostasis, but Causes Myeloid Proliferative Syndrome

tal birnberg

Immunity, 2008

View PDFchevron_right

Leukemia-Derived Immature Dendritic Cells Differentiate into Functionally Competent Mature Dendritic Cells That Efficiently Stimulate T Cell Responses

Alessandro Cignetti

The Journal of Immunology, 2004

View PDFchevron_right

The effect of dendritic cell therapy on the overall survival of patients with locally advanced or metastatic breast cancer

Jireh Ann Batac

Cytotherapy, 2015

View PDFchevron_right

Analysis of tumor-immune dynamics in a delayed dendritic cell therapy model

Yang Kuang

Chaos: An Interdisciplinary Journal of Nonlinear Science, 2020

View PDFchevron_right

Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity

marco rossi

The Journal of Immunology, 2005

View PDFchevron_right

Harnessing dendritic cells to improve allogeneic hematopoietic cell transplantation outcome

Miriam Merad

Seminars in Immunology, 2011

View PDFchevron_right

Optimal Control of Tumor Growth Model with Dendritic Cells as Immunotherapy

Abdul Rouf

The Journal of Experimental Life Sciences

View PDFchevron_right

Origin and differentiation of dendritic cells

Hector Hernandez

Trends in Immunology, 2001

View PDFchevron_right

Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer

Laura Tiberio

Frontiers in immunology, 2024

View PDFchevron_right

CD1 and Major Histocompatibility Complex II Molecules Follow a Different Course during Dendritic Cell Maturation

Gerty Schreibelt

Molecular Biology of the Cell, 2003

View PDFchevron_right

Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations

Huyen Nguyen

OncoTargets and Therapy, 2015

View PDFchevron_right

Optimization of Production of Anti-Cancer Vaccines Based on Dendritic Cells

Zélia Silva

2015

View PDFchevron_right

Tolerogenic dendritic cells: cytokine modulation comes of age

Sergio Rutella

Blood, 2006

View PDFchevron_right

Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination

Mohammad Aghasadeghi

Medical Oncology, 2011

View PDFchevron_right

The endocytic activity of dendritic cells

Joel A Swanson

Journal of Experimental Medicine

View PDFchevron_right

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)

Jamshid Hadjati

Vaccine Research, 2014

View PDFchevron_right

Dendritic cells or their exosomes are effective biotherapies of cancer

G. Raposo

European Journal of Cancer, 1999

View PDFchevron_right

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

Eric Spierings

View PDFchevron_right

Dendritic cells: function (PP-024)

Lamin Saidykhan

International Immunology, 2010

View PDFchevron_right

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer

Adriana Michielsen

PLoS ONE, 2011

View PDFchevron_right

Tumor Antigen Processing and Presentation Depend Critically on Dendritic Cell Type and the Mode of Antigen Delivery

Ian Davis

…, 2005

View PDFchevron_right

Dendritic Cell Maturation Versus Polarization in Tumor Escape

Walter Storkus

Dendritic Cells in Cancer, 2009

View PDFchevron_right

Dendritic cell-based vaccine in advanced melanoma

Emanuela Scarpi

Melanoma Research, 2011

View PDFchevron_right

Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection

LUIS ERNESTO CUADROS PAZ

Nature Immunology, 2004

View PDFchevron_right

Mechanisms of dendritic cell function

Philip King

Immunology Today, 1990

View PDFchevron_right

Evaluation of 3 Clinical Dendritic Cell Maturation Protocols Containing Lipopolysaccharide and Interferon-γ

Ping Jin

Journal of Immunotherapy, 2009

View PDFchevron_right

Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes

I. Micheva

Clinical Immunology, 2004

View PDFchevron_right

Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells

Max Bastian

The Journal of Immunology, 2005

View PDFchevron_right

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources

Priya Ramanathan

Vaccines, 2024

View PDFchevron_right